The leadership team at Carmine Therapeutics has a wealth of experience in the biotech industry. They have held positions at various companies, including Antibe Therapeutics Inc., Asklepios BioPharmaceutical, Inc. (AskBio), Sherlock Biosciences, and Histogenics Corporation. They have also been involved with Codiak BioSciences, Generation Bio, and Momenta Pharmaceuticals. In addition, they have also been involved with the Massachusetts Institute of Technology, Carcell Biopharma, EVX Ventures, A*STAR - Agency for Science, Technology and Research, Esco Ventures X, and Genome Institute of Singapore.
View all